Dr. Peter Mueller is President of the Mueller Health Foundation, a private foundation tackling globally lethal infectious diseases such as tuberculosis by addressing latency and the ever-growing challenges of antimicrobial resistance. From 2014 to 2016, Dr.

Ms. Bray brings over forty years of extensive U.S. and global regulatory experience in the healthcare industry.  She most recently served as Senior Vice President, Global Regulatory Affairs and Medical Writing at Allergan, where she was responsible for regulatory strategies on development projects

Dr. Laumas currently serves as the Chief Business Officer and Chief Financial Officer of Instil Bio, Inc. Prior to joining Instil Bio, Dr. Laumas has been actively involved in healthcare investing and serving on company Boards of Directors. He currently serves as a member of the board of directors

Mr. Mack is a senior fiduciary and restructuring and credit lawyer with nearly 30 years of finance, mergers and acquisitions, and restructuring experience in complex domestic and international litigation, leading transactions as a director, investor, and advisor.

Dr. Mehta brings over two decades of experience in the pharma and biotech industry, during which he has successfully designed and implemented innovative solutions, established global commercial operations, and led cross-functional teams. During his career, he has garnered a deep understanding of

Mr. Miller brings nearly 40 years of strategic leadership and commercial growth experience in the pharmaceutical industry, where he most recently served as Executive Vice President, U.S. Commercial at Jazz Pharmaceuticals. In this role, Mr. Miller led a 450+ person team that generated $2.3 billion

Since 2013, Mr. Votruba has been Director of the Gradus/RSJ Life Sciences Fund, the largest dedicated fund in Central Europe with a portfolio of companies in Europe and the United States. Mr. Votruba has served as a director of Mynd Analytics, Inc. (NASDAQ: MYND), a telebehavioral health services